Showing results (1-10 of 281) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|November 1, 1994
Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatinM V Relling, H L McLeod, L C Bowman, et al.Leukemia|April 14, 2000
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemiaH L McLeod, E Y Krynetski, M V Relling, et al.Blood|April 1, 1995
Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemiaH L McLeod, M V Relling, Q Liu, et al.The Journal of Clinical Investigation|May 1, 1993
Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black AmericansW E Evans, M V Relling, A Rahman, et al.Therapeutic Drug Monitoring|August 1, 1996
Are the major effects of P-glycoprotein modulators due to altered pharmacokinetics of anticancer drugs?M V RellingClinical Pharmacology and Therapeutics|May 3, 2014
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotypeM V Relling, E M McDonagh, T Chang, et al.Clinical Pharmacology and Therapeutics|March 7, 2007
Should pharmacogenomic studies be required for new drug approval?M V Relling, J M HoffmanPageof 29